In hepatocellular carcinoma, even malignant peripheral nerve sheath tumors (MPNSTs), CDK4/6is cause tumors to be more sensitive to PD-L1 blockade therapy by increasing the expression of PD-L1 [43,80]. This evidence concerns the gene CD274 and malignant peripheral nerve sheath tumor.